Canada Markets close in 6 hrs 22 mins

Twist Bioscience Corporation (TWST)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
69.65+3.95 (+6.01%)
As of 9:38AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close65.70
Open66.38
Bid68.58 x 900
Ask69.38 x 1000
Day's Range66.00 - 69.65
52 Week Range18.52 - 69.65
Volume13,721
Avg. Volume542,729
Market Cap3.097B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-4.41
Earnings DateAug. 06, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est47.00
  • Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
    Zacks

    Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates

    Twist Bioscience (TWST) delivered earnings and revenue surprises of 6.94% and 56.89%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

  • Twist Bioscience Reports Third Quarter Fiscal 2020 Financial Results
    Business Wire

    Twist Bioscience Reports Third Quarter Fiscal 2020 Financial Results

    Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the third quarter of fiscal 2020, ended June 30, 2020.

  • Seismic Bio Partners With Twist Bioscience for Discovery and Optimization of Antibodies
    Business Wire

    Seismic Bio Partners With Twist Bioscience for Discovery and Optimization of Antibodies

    Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Seismic Bio, Inc., an immuno-oncology company focused on bispecific antibody development, today announced a partnership for the discovery and optimization of antibodies to high-value immuno-oncology targets.